Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


21.01.2019

1 Am J Hematol
2 Ann Hematol
4 Blood
1 BMC Cancer
1 Bone Marrow Transplant
1 Clin Infect Dis
1 Gene
1 Int J Hematol
1 J Biol Chem
2 J Pediatr Hematol Oncol
14 Leuk Lymphoma
4 Leuk Res
5 Leukemia
3 N Engl J Med
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. QASIM W
    Allogeneic CAR T cell therapies for leukemia - R1.
    Am J Hematol. 2019 Jan 11. doi: 10.1002/ajh.25399.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. LIU B, Wang Y, Zhou C, Wei H, et al
    Nilotinib combined with multi-agent chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center prospective study with long-term follow-up.
    Ann Hematol. 2019 Jan 11. pii: 10.1007/s00277-019-03594.
    PubMed     Text format     Abstract available

  3. LIU L, Zhang X, Qiu H, Tang X, et al
    HLA-mismatched stem cell microtransplantation compared to matched-sibling donor transplantation for intermediate/high-risk acute myeloid leukemia.
    Ann Hematol. 2019 Jan 10. pii: 10.1007/s00277-018-3583.
    PubMed     Text format     Abstract available


    Blood

  4. STEPHENS DM, Byrd JC
    How we manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.
    Blood. 2019 Jan 14. pii: blood-2018-11-846808. doi: 10.1182/blood-2018-11-846808
    PubMed     Text format     Abstract available

  5. HALLNER A, Bernson E, Hussein BA, Sander FE, et al
    The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.
    Blood. 2019 Jan 15. pii: blood-2018-09-874990. doi: 10.1182/blood-2018-09-874990
    PubMed     Text format     Abstract available

  6. TORUNER GA, Thakral B
    Relapsed NPM1 mutated acute myeloid leukemia with PDGFRA rearrangement.
    Blood. 2019;133:181.
    PubMed     Text format    

  7. XIE W, Xu J
    Neutrophilic leukemoid reaction associated with plasma cell neoplasm mimicking chronic neutrophilic leukemia.
    Blood. 2019;133:182.
    PubMed     Text format    


    BMC Cancer

  8. PIEDIMONTE M, Ottone T, Alfonso V, Ferrari A, et al
    A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    BMC Cancer. 2019;19:50.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  9. QU C, Li Z, Kang L, Wang Y, et al
    Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.
    Bone Marrow Transplant. 2019 Jan 10. pii: 10.1038/s41409-018-0423.
    PubMed     Text format    


    Clin Infect Dis

  10. PAPANICOLAOU GA, Ustun C, Young JH, Chen M, et al
    Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.
    Clin Infect Dis. 2019 Jan 14. pii: 5289185. doi: 10.1093.
    PubMed     Text format     Abstract available


    Gene

  11. POUYANRAD S, Rahgozar S, Ghodousi ES
    Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
    Gene. 2019 Jan 10. pii: S0378-1119(19)30018-6. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


    Int J Hematol

  12. BRUNETTI L, Gundry MC, Goodell MA
    New insights into the biology of acute myeloid leukemia with mutated NPM1.
    Int J Hematol. 2019 Jan 10. pii: 10.1007/s12185-018-02578.
    PubMed     Text format     Abstract available


    J Biol Chem

  13. MIYANOKOSHI M, Yokosawa T, Wakasugi K
    Tryptophanyl-tRNA synthetase mediates high-affinity tryptophan uptake into human cells.
    J Biol Chem. 2018;293:8428-8438.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  14. LIAO C, Xu X, Shen D, Song H, et al
    Minimal Residual Disease-guided Risk Restratification and Therapy Improves the Survival of Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Children's Hospital in China.
    J Pediatr Hematol Oncol. 2019 Jan 11. doi: 10.1097/MPH.0000000000001412.
    PubMed     Text format     Abstract available

  15. GIORDANO P, Grassi M, Saracco P, Luciani M, et al
    Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children With Acute Lymphoblastic Leukemia: Results of a Retrospective Survey.
    J Pediatr Hematol Oncol. 2019 Jan 11. doi: 10.1097/MPH.0000000000001390.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  16. TEH BW, Chui W, Handunnetti S, Tam C, et al
    High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
    Leuk Lymphoma. 2019 Jan 11:1-4. doi: 10.1080/10428194.2018.1543884.
    PubMed     Text format    

  17. SADIGH S, Morrissette JJD, Bagg A
    FBXW7 mutations in acute myeloid leukemia.
    Leuk Lymphoma. 2019 Jan 11:1-2. doi: 10.1080/10428194.2018.1537488.
    PubMed     Text format    

  18. DANESE MD, Katz A, Cetin K, Chia V, et al
    Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data.
    Leuk Lymphoma. 2019 Jan 11:1-10. doi: 10.1080/10428194.2018.1555329.
    PubMed     Text format     Abstract available

  19. SATO E, Iriyama N, Tokuhira M, Takaku T, et al
    Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score.
    Leuk Lymphoma. 2018;59:1105-1112.
    PubMed     Text format     Abstract available

  20. PRESS KR, Uy N, Keefer J, Gore SD, et al
    Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes.
    Leuk Lymphoma. 2018;59:755-757.
    PubMed     Text format    

  21. HIRAI M, Yagasaki H, Fujimura J, Inoue M, et al
    Successful preemptive donor lymphocyte infusions from a haploidentical donor in a boy with E2A-HLF-positive ALL.
    Leuk Lymphoma. 2018;59:746-748.
    PubMed     Text format    

  22. BODDU P, Gibbons J, Burger J, Sivina M, et al
    Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases.
    Leuk Lymphoma. 2019 Jan 11:1-4. doi: 10.1080/10428194.2018.1547902.
    PubMed     Text format    

  23. LASICA M, Willcox A, Burbury K, Ross DM, et al
    The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.
    Leuk Lymphoma. 2019 Jan 11:1-7. doi: 10.1080/10428194.2018.1551533.
    PubMed     Text format     Abstract available

  24. KERMEZLI Y, Saadi W, Belhocine M, Mathieu EL, et al
    A comprehensive catalog of LncRNAs expressed in T-cell acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Jan 16:1-13. doi: 10.1080/10428194.2018.1551534.
    PubMed     Text format     Abstract available

  25. SHEN Y, Crassini K, Sandhu S, Fatima N, et al
    Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment.
    Leuk Lymphoma. 2019 Jan 16:1-12. doi: 10.1080/10428194.2018.1542148.
    PubMed     Text format     Abstract available

  26. QUINTAS-CARDAMA A
    CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.
    Leuk Lymphoma. 2019 Jan 16:1-3. doi: 10.1080/10428194.2018.1533132.
    PubMed     Text format    

  27. AWAN FT, Thirman MJ, Patel-Donnelly D, Assouline S, et al
    Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study.
    Leuk Lymphoma. 2019 Jan 11:1-6. doi: 10.1080/10428194.2018.1562180.
    PubMed     Text format     Abstract available

  28. ZHANG X, Li F, Wang J, Suo S, et al
    RARgamma-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen.
    Leuk Lymphoma. 2019 Jan 11:1-4. doi: 10.1080/10428194.2018.1553302.
    PubMed     Text format    

  29. ALBERTSEN BK, Harila-Saari A, Jahnukainen K, Lahteenmaki P, et al
    Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06.
    Leuk Lymphoma. 2019 Jan 11:1-7. doi: 10.1080/10428194.2018.1538507.
    PubMed     Text format     Abstract available


    Leuk Res

  30. HU Z, Hu S, Ji C, Tang Z, et al
    3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Leuk Res. 2018;65:25-28.
    PubMed     Text format     Abstract available

  31. KUMAR A, Drusbosky LM, Meacham A, Turcotte M, et al
    Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
    Leuk Res. 2019;78:3-11.
    PubMed     Text format     Abstract available

  32. SCHULER E, Frank F, Hildebrandt B, Betz B, et al
    Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Leuk Res. 2018;65:1-4.
    PubMed     Text format     Abstract available

  33. HENRY D, Brumaire S, Hu X
    Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells.
    Leuk Res. 2019;77:34-41.
    PubMed     Text format     Abstract available


    Leukemia

  34. REDA G, Cassin R, Gentile M, Mauro FR, et al
    IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.
    Leukemia. 2019 Jan 11. pii: 10.1038/s41375-018-0344.
    PubMed     Text format    

  35. HOANG VT, Verma D, Godavarthy PS, Llavona P, et al
    The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia.
    Leukemia. 2019 Jan 11. pii: 10.1038/s41375-018-0358.
    PubMed     Text format     Abstract available

  36. OZTURK S, Roessner PM, Schulze-Edinghausen L, Yazdanparast H, et al
    Rejection of adoptively transferred Emicro-TCL1 chronic lymphocytic leukemia cells in C57BL/6 substrains or knockout mouse lines.
    Leukemia. 2019 Jan 11. pii: 10.1038/s41375-018-0332.
    PubMed     Text format    

  37. JAWHAR M, Dohner K, Kreil S, Schwaab J, et al
    KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
    Leukemia. 2019 Jan 11. pii: 10.1038/s41375-018-0346.
    PubMed     Text format     Abstract available

  38. LOPEZ-MILLAN B, Sanchez-Martinez D, Roca-Ho H, Gutierrez-Aguera F, et al
    NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
    Leukemia. 2019 Jan 11. pii: 10.1038/s41375-018-0353.
    PubMed     Text format     Abstract available


    N Engl J Med

  39. YAMAUCHI J, Yamano Y, Yuzawa K
    Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation.
    N Engl J Med. 2019;380:296-298.
    PubMed     Text format    

  40. WOYACH JA, Ruppert AS, Heerema NA, Zhao W, et al
    Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
    N Engl J Med. 2018;379:2517-2528.
    PubMed     Text format     Abstract available

  41. CHRISTOPHER MJ, Petti AA, Rettig MP, Miller CA, et al
    Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
    N Engl J Med. 2018;379:2330-2341.
    PubMed     Text format     Abstract available


    Oncogene

  42. KARVONEN H, Perttila R, Niininen W, Hautanen V, et al
    Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Oncogene. 2019 Jan 10. pii: 10.1038/s41388-018-0670.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: